According to latest Research, the global market for Prescription Digital Therapeutics (PDT) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Prescription Digital Therapeutics (PDT) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Prescription Digital Therapeutics (PDT) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Medication Augmentation segment holds a share about % in 2023 and will reach % in 2029; while in terms of application, Children has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Prescription Digital Therapeutics (PDT) include Akili Interactive, Pear Therapeutics, Better Therapeutics, ResMed, Biofourmis, Novartis, Medtronic, Voluntis and Omada Health, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Prescription digital therapeutics is a form of software-based therapeutics used to treat a wide range of illnesses. Technology and biology are combined to make prescription digital medications. These therapeutic tools were created using artificial intelligence, several algorithms, and virtual reality. Prescription PDTs, or digital therapeutics, are a brand-new medicinal category. PDTs act as direct treatments for critical disorders such as conventional biologics or medications.
This report aims to provide a comprehensive study of the global market for Prescription Digital Therapeutics (PDT). Report Highlights:
(1) Global Prescription Digital Therapeutics (PDT) market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Prescription Digital Therapeutics (PDT) market competitive situation, revenue and market share, from 2019 to 2024.
(3) China Prescription Digital Therapeutics (PDT) market competitive situation, revenue and market share, from 2019 to 2024.
(4) Global Prescription Digital Therapeutics (PDT) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Prescription Digital Therapeutics (PDT) segment by type and by application and regional segment by type and by application.
(6) Prescription Digital Therapeutics (PDT) industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Medication Augmentation
Medication Replacement
Market segment by application, can be divided into
Children
Adults
Market segment by players, this report covers
Akili Interactive
Pear Therapeutics
Better Therapeutics
ResMed
Biofourmis
Novartis
Medtronic
Voluntis
Omada Health
GAIA
Solera Network
BigHealth
Click Therapeutics
Happify
Limbix Health
Naturalcycles Nordic
NuvoAir
Sensyne Health
Xealth
1 Market Overview
1.1 Product Overview and Scope of Prescription Digital Therapeutics (PDT)
1.2 Global Prescription Digital Therapeutics (PDT) Market Size and Forecast
1.3 China Prescription Digital Therapeutics (PDT) Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Prescription Digital Therapeutics (PDT) Share in Global Market, 2019-2030
1.4.2 Prescription Digital Therapeutics (PDT) Market Size: China VS Global, 2019-2030
1.5 Prescription Digital Therapeutics (PDT) Market Dynamics
1.5.1 Prescription Digital Therapeutics (PDT) Market Drivers
1.5.2 Prescription Digital Therapeutics (PDT) Market Restraints
1.5.3 Prescription Digital Therapeutics (PDT) Industry Trends
1.5.4 Prescription Digital Therapeutics (PDT) Industry Policy
2 Global Competitive Situation by Company
2.1 Global Prescription Digital Therapeutics (PDT) Revenue by Company (2019-2024)
2.2 Global Prescription Digital Therapeutics (PDT) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Prescription Digital Therapeutics (PDT) Concentration Ratio
2.4 Global Prescription Digital Therapeutics (PDT) Mergers & Acquisitions, Expansion Plans
2.5 Global Prescription Digital Therapeutics (PDT) Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Prescription Digital Therapeutics (PDT) Revenue by Company (2019-2024)
3.2 China Prescription Digital Therapeutics (PDT) Prescription Digital Therapeutics (PDT) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Prescription Digital Therapeutics (PDT), Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Prescription Digital Therapeutics (PDT) Industry Chain
4.2 Prescription Digital Therapeutics (PDT) Upstream Analysis
4.3 Prescription Digital Therapeutics (PDT) Midstream Analysis
4.4 Prescription Digital Therapeutics (PDT) Downstream Analysis
5 Sights by Type
5.1 Prescription Digital Therapeutics (PDT) Classification
5.1.1 Medication Augmentation
5.1.2 Medication Replacement
5.2 By Type, Global Prescription Digital Therapeutics (PDT) Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030
6 Sights by Application
6.1 Prescription Digital Therapeutics (PDT) Segment by Application
6.1.1 Children
6.1.2 Adults
6.2 By Application, Global Prescription Digital Therapeutics (PDT) Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Prescription Digital Therapeutics (PDT) Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
7.3 North America
7.3.1 North America Prescription Digital Therapeutics (PDT) Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Prescription Digital Therapeutics (PDT) Market Size Market Share
7.4 Europe
7.4.1 Europe Prescription Digital Therapeutics (PDT) Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Prescription Digital Therapeutics (PDT) Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Prescription Digital Therapeutics (PDT) Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Prescription Digital Therapeutics (PDT) Market Size Market Share
7.6 South America
7.6.1 South America Prescription Digital Therapeutics (PDT) Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Prescription Digital Therapeutics (PDT) Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Prescription Digital Therapeutics (PDT) Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.3.2 By Company, U.S. Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.3.4 By Application, U.S. Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.4 Europe
8.4.1 Europe Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.4.2 By Company, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.4.4 By Application, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.5 China
8.5.1 China Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.5.2 By Company, China Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.5.3 By Type, China Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.5.4 By Application, China Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.6 Japan
8.6.1 Japan Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.6.2 By Company, Japan Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.6.4 By Application, Japan Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.7.2 By Company, South Korea Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.7.4 By Application, South Korea Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.8.4 By Application, Southeast Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.9 India
8.9.1 India Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.9.2 By Company, India Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.9.3 By Type, India Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.9.4 By Application, India Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Prescription Digital Therapeutics (PDT) Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
8.10.4 By Application, Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2024 VS 2030
9 Global Manufacturers Profile
9.1 Akili Interactive
9.1.1 Akili Interactive Company Information, Head Office, Market Area and Industry Position
9.1.2 Akili Interactive Company Profile and Main Business
9.1.3 Akili Interactive Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.1.4 Akili Interactive Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.1.5 Akili Interactive Recent Developments
9.2 Pear Therapeutics
9.2.1 Pear Therapeutics Company Information, Head Office, Market Area and Industry Position
9.2.2 Pear Therapeutics Company Profile and Main Business
9.2.3 Pear Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.2.4 Pear Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.2.5 Pear Therapeutics Recent Developments
9.3 Better Therapeutics
9.3.1 Better Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Better Therapeutics Company Profile and Main Business
9.3.3 Better Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.3.4 Better Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.3.5 Better Therapeutics Recent Developments
9.4 ResMed
9.4.1 ResMed Company Information, Head Office, Market Area and Industry Position
9.4.2 ResMed Company Profile and Main Business
9.4.3 ResMed Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.4.4 ResMed Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.4.5 ResMed Recent Developments
9.5 Biofourmis
9.5.1 Biofourmis Company Information, Head Office, Market Area and Industry Position
9.5.2 Biofourmis Company Profile and Main Business
9.5.3 Biofourmis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.5.4 Biofourmis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.5.5 Biofourmis Recent Developments
9.6 Novartis
9.6.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.6.2 Novartis Company Profile and Main Business
9.6.3 Novartis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.6.4 Novartis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.6.5 Novartis Recent Developments
9.7 Medtronic
9.7.1 Medtronic Company Information, Head Office, Market Area and Industry Position
9.7.2 Medtronic Company Profile and Main Business
9.7.3 Medtronic Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.7.4 Medtronic Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.7.5 Medtronic Recent Developments
9.8 Voluntis
9.8.1 Voluntis Company Information, Head Office, Market Area and Industry Position
9.8.2 Voluntis Company Profile and Main Business
9.8.3 Voluntis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.8.4 Voluntis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.8.5 Voluntis Recent Developments
9.9 Omada Health
9.9.1 Omada Health Company Information, Head Office, Market Area and Industry Position
9.9.2 Omada Health Company Profile and Main Business
9.9.3 Omada Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.9.4 Omada Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.9.5 Omada Health Recent Developments
9.10 GAIA
9.10.1 GAIA Company Information, Head Office, Market Area and Industry Position
9.10.2 GAIA Company Profile and Main Business
9.10.3 GAIA Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.10.4 GAIA Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.10.5 GAIA Recent Developments
9.11 Solera Network
9.11.1 Solera Network Company Information, Head Office, Market Area and Industry Position
9.11.2 Solera Network Company Profile and Main Business
9.11.3 Solera Network Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.11.4 Solera Network Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.11.5 Solera Network Recent Developments
9.12 BigHealth
9.12.1 BigHealth Company Information, Head Office, Market Area and Industry Position
9.12.2 BigHealth Company Profile and Main Business
9.12.3 BigHealth Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.12.4 BigHealth Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.12.5 BigHealth Recent Developments
9.13 Click Therapeutics
9.13.1 Click Therapeutics Company Information, Head Office, Market Area and Industry Position
9.13.2 Click Therapeutics Company Profile and Main Business
9.13.3 Click Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.13.4 Click Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.13.5 Click Therapeutics Recent Developments
9.14 Happify
9.14.1 Happify Company Information, Head Office, Market Area and Industry Position
9.14.2 Happify Company Profile and Main Business
9.14.3 Happify Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.14.4 Happify Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.14.5 Happify Recent Developments
9.15 Limbix Health
9.15.1 Limbix Health Company Information, Head Office, Market Area and Industry Position
9.15.2 Limbix Health Company Profile and Main Business
9.15.3 Limbix Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.15.4 Limbix Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.15.5 Limbix Health Recent Developments
9.16 Naturalcycles Nordic
9.16.1 Naturalcycles Nordic Company Information, Head Office, Market Area and Industry Position
9.16.2 Naturalcycles Nordic Company Profile and Main Business
9.16.3 Naturalcycles Nordic Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.16.4 Naturalcycles Nordic Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.16.5 Naturalcycles Nordic Recent Developments
9.17 NuvoAir
9.17.1 NuvoAir Company Information, Head Office, Market Area and Industry Position
9.17.2 NuvoAir Company Profile and Main Business
9.17.3 NuvoAir Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.17.4 NuvoAir Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.17.5 NuvoAir Recent Developments
9.18 Sensyne Health
9.18.1 Sensyne Health Company Information, Head Office, Market Area and Industry Position
9.18.2 Sensyne Health Company Profile and Main Business
9.18.3 Sensyne Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.18.4 Sensyne Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.18.5 Sensyne Health Recent Developments
9.19 Xealth
9.19.1 Xealth Company Information, Head Office, Market Area and Industry Position
9.19.2 Xealth Company Profile and Main Business
9.19.3 Xealth Prescription Digital Therapeutics (PDT) Models, Specifications and Application
9.19.4 Xealth Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
9.19.5 Xealth Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Prescription Digital Therapeutics (PDT) Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Prescription Digital Therapeutics (PDT) Market Restraints
Table 3. Prescription Digital Therapeutics (PDT) Market Trends
Table 4. Prescription Digital Therapeutics (PDT) Industry Policy
Table 5. Global Prescription Digital Therapeutics (PDT) Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Prescription Digital Therapeutics (PDT) Revenue Market Share by Company (2019-2024)
Table 7. Global Prescription Digital Therapeutics (PDT) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Prescription Digital Therapeutics (PDT) Mergers & Acquisitions, Expansion Plans
Table 9. Global Prescription Digital Therapeutics (PDT) Manufacturers Product Type
Table 10. China Prescription Digital Therapeutics (PDT) Revenue by Company (2019-2024) & (US$ million)
Table 11. China Prescription Digital Therapeutics (PDT) Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Prescription Digital Therapeutics (PDT) Upstream (Raw Materials)
Table 13. Global Prescription Digital Therapeutics (PDT) Typical Customers
Table 14. Prescription Digital Therapeutics (PDT) Typical Distributors
Table 15. By Type, Global Prescription Digital Therapeutics (PDT) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Prescription Digital Therapeutics (PDT) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Prescription Digital Therapeutics (PDT) Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Prescription Digital Therapeutics (PDT) Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2030
Table 22. Akili Interactive Company Information, Head Office, Market Area and Industry Position
Table 23. Akili Interactive Company Profile and Main Business
Table 24. Akili Interactive Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 25. Akili Interactive Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 26. Akili Interactive Recent Developments
Table 27. Pear Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 28. Pear Therapeutics Company Profile and Main Business
Table 29. Pear Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 30. Pear Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 31. Pear Therapeutics Recent Developments
Table 32. Better Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 33. Better Therapeutics Company Profile and Main Business
Table 34. Better Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 35. Better Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 36. Better Therapeutics Recent Developments
Table 37. ResMed Company Information, Head Office, Market Area and Industry Position
Table 38. ResMed Company Profile and Main Business
Table 39. ResMed Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 40. ResMed Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 41. ResMed Recent Developments
Table 42. Biofourmis Company Information, Head Office, Market Area and Industry Position
Table 43. Biofourmis Company Profile and Main Business
Table 44. Biofourmis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 45. Biofourmis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 46. Biofourmis Recent Developments
Table 47. Novartis Company Information, Head Office, Market Area and Industry Position
Table 48. Novartis Company Profile and Main Business
Table 49. Novartis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 50. Novartis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 51. Novartis Recent Developments
Table 52. Medtronic Company Information, Head Office, Market Area and Industry Position
Table 53. Medtronic Company Profile and Main Business
Table 54. Medtronic Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 55. Medtronic Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 56. Medtronic Recent Developments
Table 57. Voluntis Company Information, Head Office, Market Area and Industry Position
Table 58. Voluntis Company Profile and Main Business
Table 59. Voluntis Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 60. Voluntis Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 61. Voluntis Recent Developments
Table 62. Omada Health Company Information, Head Office, Market Area and Industry Position
Table 63. Omada Health Company Profile and Main Business
Table 64. Omada Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 65. Omada Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 66. Omada Health Recent Developments
Table 67. GAIA Company Information, Head Office, Market Area and Industry Position
Table 68. GAIA Company Profile and Main Business
Table 69. GAIA Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 70. GAIA Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 71. GAIA Recent Developments
Table 72. Solera Network Company Information, Head Office, Market Area and Industry Position
Table 73. Solera Network Company Profile and Main Business
Table 74. Solera Network Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 75. Solera Network Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 76. Solera Network Recent Developments
Table 77. BigHealth Company Information, Head Office, Market Area and Industry Position
Table 78. BigHealth Company Profile and Main Business
Table 79. BigHealth Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 80. BigHealth Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 81. BigHealth Recent Developments
Table 82. Click Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 83. Click Therapeutics Company Profile and Main Business
Table 84. Click Therapeutics Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 85. Click Therapeutics Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 86. Click Therapeutics Recent Developments
Table 87. Happify Company Information, Head Office, Market Area and Industry Position
Table 88. Happify Company Profile and Main Business
Table 89. Happify Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 90. Happify Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 91. Happify Recent Developments
Table 92. Limbix Health Company Information, Head Office, Market Area and Industry Position
Table 93. Limbix Health Company Profile and Main Business
Table 94. Limbix Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 95. Limbix Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 96. Limbix Health Recent Developments
Table 97. Naturalcycles Nordic Company Information, Head Office, Market Area and Industry Position
Table 98. Naturalcycles Nordic Company Profile and Main Business
Table 99. Naturalcycles Nordic Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 100. Naturalcycles Nordic Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 101. Naturalcycles Nordic Recent Developments
Table 102. NuvoAir Company Information, Head Office, Market Area and Industry Position
Table 103. NuvoAir Company Profile and Main Business
Table 104. NuvoAir Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 105. NuvoAir Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 106. NuvoAir Recent Developments
Table 107. Sensyne Health Company Information, Head Office, Market Area and Industry Position
Table 108. Sensyne Health Company Profile and Main Business
Table 109. Sensyne Health Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 110. Sensyne Health Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 111. Sensyne Health Recent Developments
Table 112. Xealth Company Information, Head Office, Market Area and Industry Position
Table 113. Xealth Company Profile and Main Business
Table 114. Xealth Prescription Digital Therapeutics (PDT) Models, Specifications and Application
Table 115. Xealth Prescription Digital Therapeutics (PDT) Revenue and Gross Margin, 2019-2024
Table 116. Xealth Recent Developments
List of Figure
Figure 1. Prescription Digital Therapeutics (PDT) Picture
Figure 2. Global Prescription Digital Therapeutics (PDT) Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Prescription Digital Therapeutics (PDT) Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Prescription Digital Therapeutics (PDT) Market Share of Global
Figure 5. Global Prescription Digital Therapeutics (PDT) Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 6. Global Prescription Digital Therapeutics (PDT) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Prescription Digital Therapeutics (PDT) Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 8. China Prescription Digital Therapeutics (PDT) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Prescription Digital Therapeutics (PDT) Industry Chain
Figure 10. Medication Augmentation
Figure 11. Medication Replacement
Figure 12. By Type, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, US$ Million
Figure 13. By Type, Global Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2030
Figure 14. Children
Figure 15. Adults
Figure 16. By Application, Global Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, US$ Million
Figure 17. By Application, Global Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2030
Figure 18. By Region, Global Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2030
Figure 19. North America Prescription Digital Therapeutics (PDT) Revenue & Forecasts, 2019-2030, US$ Million
Figure 20. By Country, North America Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
Figure 21. Europe Prescription Digital Therapeutics (PDT) Revenue & Forecasts, 2019-2030, US$ Million
Figure 22. By Country, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
Figure 23. Asia Pacific Prescription Digital Therapeutics (PDT) Revenue & Forecasts, 2019-2030, US$ Million
Figure 24. By Country/Region, Asia Pacific Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
Figure 25. South America Prescription Digital Therapeutics (PDT) Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, South America Prescription Digital Therapeutics (PDT) Revenue Market Share, 2019-2024
Figure 27. Middle East & Africa Prescription Digital Therapeutics (PDT) Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. U.S. Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 29. By Company, U.S. Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 30. By Type, U.S. Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 31. By Application, U.S. Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 32. Europe Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 33. By Company, Europe Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 34. By Type, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 35. By Application, Europe Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 36. China Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 37. By Company, China Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 38. By Type, China Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 39. By Application, China Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 40. Japan Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 41. By Company, Japan Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 42. By Type, Japan Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 43. By Application, Japan Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 44. South Korea Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 45. By Company, South Korea Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 46. By Type, South Korea Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 47. By Application, South Korea Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 48. Southeast Asia Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 49. By Company, Southeast Asia Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 50. By Type, Southeast Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 51. By Application, Southeast Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 52. India Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 53. By Company, India Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 54. By Type, India Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 55. By Application, India Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 56. Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue, 2019-2030, (US$ Million)
Figure 57. By Company, Middle East & Asia Prescription Digital Therapeutics (PDT) Market Share, 2019-2024
Figure 58. By Type, Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 59. By Application, Middle East & Asia Prescription Digital Therapeutics (PDT) Revenue Market Share, 2023 VS 2029
Figure 60. Research Methodology
Figure 61. Breakdown of Primary Interviews
Figure 62. Bottom-up Approaches
Figure 63. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|